Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Crane Rosemary A
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Goldberg Andrew D.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LINK WILLIAM J PHD
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lin Elizabeth Yeu
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CHAUDHURI BHASKAR
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director YARNO WENDY L
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Farrow Jeffrey S
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Goldberg Andrew D.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CHAUDHURI BHASKAR
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Crane Rosemary A
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director YARNO WENDY L
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lin Elizabeth Yeu
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LINK WILLIAM J PHD
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottiwala Aziz
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wahl Bryan
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Azamian Bobak R.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Whitfield Dianne C.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Neervannan Seshadri
No Data